{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:44:09Z","timestamp":1790160249896,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1407,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.exphem.2018.04.007","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T21:29:30Z","timestamp":1525469370000},"page":"71-83.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Experimental and integrative analyses identify an ETS1 network downstream of BCR-ABL in chronic myeloid leukemia (CML)"],"prefix":"10.1016","volume":"64","author":[{"given":"Christophe","family":"Desterke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Voldoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Sorel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Rahban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise","family":"Bennaceur-Griscelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Cayssials","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Chomel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali G.","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2018.04.007_bib0001","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajh.24275","article-title":"Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring","volume":"91","author":"Jabbour","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2018.04.007_bib0002","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.007_bib0003","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2018.04.007_bib0004","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V82.6.1838.1838","article-title":"Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells","volume":"82","author":"Mandanas","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.007_bib0005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0092-8674(92)90241-4","article-title":"Dominant negative MYC blocks transformation by ABL oncogenes","volume":"70","author":"Sawyers","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2018.04.007_bib0006","first-page":"247","article-title":"Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia","volume":"13","author":"Shuai","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2018.04.007_bib0007","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1200\/JCO.2015.66.2866","article-title":"Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population","volume":"34","author":"Bower","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2018.04.007_bib0008","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1182\/blood-2011-02-335497","article-title":"Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease","volume":"118","author":"Chomel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.007_bib0009","doi-asserted-by":"crossref","first-page":"35293","DOI":"10.18632\/oncotarget.9182","article-title":"Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation","volume":"7","author":"Chomel","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.exphem.2018.04.007_bib0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/10428194.2010.546912","article-title":"Chronic myeloid leukemia cells refractory\/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease state","volume":"52","author":"Skorski","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2018.04.007_bib0011","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"Hamilton","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.007_bib0012","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature18288","article-title":"Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells","volume":"534","author":"Abraham","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.04.007_bib0013","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1172\/JCI41246","article-title":"Chronic myeloid leukemia: mechanisms of blastic transformation","volume":"120","author":"Perrotti","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2018.04.007_bib0014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.18632\/oncoscience.9","article-title":"Modeling the influence of stromal microenvironment in the selection of ENU-induced BCR-ABL1 mutants by tyrosine kinase inhibitors","volume":"1","author":"Aggoune","year":"2014","journal-title":"Oncoscience"},{"key":"10.1016\/j.exphem.2018.04.007_bib0015","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood.V97.7.2084","article-title":"BCR-ABL down-regulatesthe DNA repair protein DNA-PKcs","volume":"97","author":"Deutsch","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.007_bib0016","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1182\/blood-2002-10-3011","article-title":"Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells","volume":"101","author":"Deutsch","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.007_bib0017","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev.biochem.79.081507.103945","article-title":"Genomic and biochemical insights into the specificity of ETS transcription factors","volume":"80","author":"Hollenhorst","year":"2011","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.exphem.2018.04.007_bib0018","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3324\/haematol.2010.023267","article-title":"Transcriptional silencing of the ETS1 oncogene contributes to human granulocytic differentiation","volume":"95","author":"Lulli","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2018.04.007_bib0019","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/sj.leu.2401730","article-title":"Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7","volume":"14","author":"Issaad","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.04.007_bib0020","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/leu.2015.29","article-title":"Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia","volume":"29","author":"Cross","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.04.007_bib0021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molcel.2013.08.037","article-title":"Distinct properties of cell-type-specific and shared transcription factor binding sites","volume":"52","author":"Gertz","year":"2013","journal-title":"Mol Cell"},{"issue":"8","key":"10.1016\/j.exphem.2018.04.007_bib0022","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2018.04.007_bib0023","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1182\/blood-2009-03-210732","article-title":"A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib","volume":"115","author":"McWeeney","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.007_bib0024","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2018.04.007_bib0025","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2018.04.007_bib0026","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1038\/nprot.2013.150","article-title":"Target analysis by integration of transcriptome and ChIP-seq data with BETA","volume":"8","author":"Wang","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.exphem.2018.04.007_bib0027","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.1630","article-title":"GREAT improves functional interpretation of cis-regulatory regions","volume":"28","author":"McLean","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.exphem.2018.04.007_bib0028","doi-asserted-by":"crossref","first-page":"W187","DOI":"10.1093\/nar\/gku365","article-title":"deepTools: a flexible platform for exploring deep-sequencing data","volume":"42","author":"Ram\u00edrez","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2018.04.007_bib0029","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1007\/s00277-015-2322-2","article-title":"A review of the European LeukemiaNet recommendations for the management of CML","volume":"94","author":"Baccarani","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2018.04.007_bib0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/306395a0","article-title":"A putative second cell-derived oncogene of the avian leukaemia retrovirus E26","volume":"306","author":"Leprince","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.04.007_bib0031","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S1357-2725(97)00086-1","article-title":"The ETS-domain transcriptionfactor family","volume":"29","author":"Sharrocks","year":"1997","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.exphem.2018.04.007_bib0032","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/sj.cdd.4401811","article-title":"Overexpression of Ets-1 inhuman hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation","volume":"13","author":"Lulli","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2018.04.007_bib0033","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.onc.1202407","article-title":"Polarized distribution of Bcr-Abl in migrating myeloid cells and co-localization of Bcr-Abl and its target proteins","volume":"18","author":"Skourides","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2018.04.007_bib0034","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1242\/dev.065268","article-title":"CTCF: insights into insulator function during development","volume":"139","author":"Herold","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.exphem.2018.04.007_bib0035","first-page":"5718","article-title":"Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro","volume":"9","author":"Boulukos","year":"1989","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2018.04.007_bib0036","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-4598-2-29","article-title":"The biology of the Ets1 proto-oncogene","volume":"2","author":"Dittmer","year":"2003","journal-title":"Mol Cancer"},{"key":"10.1016\/j.exphem.2018.04.007_bib0037","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.leu.2403241","article-title":"JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis","volume":"18","author":"Steelman","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.04.007_bib0038","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/MCB.16.2.538","article-title":"Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2","volume":"16","author":"Yang","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2018.04.007_bib0039","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/dna.2005.24.126","article-title":"Ets1 was significantly activated by ERK1\/2 in mutant K-ras stably transfected human adrenocortical cells","volume":"24","author":"Chen","year":"2005","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.exphem.2018.04.007_bib0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1349-7006.2009.01365.x","article-title":"Contribution of BCR-ABL-independent activation of ERK1\/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells","volume":"101","author":"Nambu","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.exphem.2018.04.007_bib0041","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1038\/sj.onc.1203542","article-title":"IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells","volume":"19","author":"Rameil","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2018.04.007_bib0042","doi-asserted-by":"crossref","first-page":"45529","DOI":"10.1074\/jbc.M206327200","article-title":"Structural analysis of the autoinhibition of Ets-1 and its role in protein partnerships","volume":"277","author":"Garvie","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2018.04.007_bib0043","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood-2007-07-102533","article-title":"RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance","volume":"111","author":"Roche-Lestienne","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.04.007_bib0044","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1073\/pnas.83.6.1714","article-title":"Identification and preferential expression in thymic and bursal lymphocytes of a c-ets oncogene-encoded Mr 54,000 cytoplasmic protein","volume":"83","author":"Ghysdael","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2018.04.007_bib0045","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1242\/dev.126.14.3131","article-title":"Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage","volume":"126","author":"Anderson","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.exphem.2018.04.007_bib0046","doi-asserted-by":"crossref","first-page":"28143","DOI":"10.1016\/S0021-9258(18)46906-2","article-title":"Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity","volume":"269","author":"Rabault","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2018.04.007_bib0047","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/j.1460-2075.1988.tb02904.x","article-title":"Mitogenic stimulation of thymocytes results in the calcium-dependent phosphorylation of c-ets-1 proteins","volume":"7","author":"Pognonec","year":"1988","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2018.04.007_bib0048","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1091\/mbc.e02-03-0149","article-title":"Calcium regulation of GM-CSF by calmodulin-dependent kinase II phosphorylation of Ets1","volume":"13","author":"Liu","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.exphem.2018.04.007_bib0049","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/leu.2016.53","article-title":"Aberrant activation of CaMKII\u03b3 accelerates chronic myeloid leukemia blast crisis","volume":"30","author":"Gu","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.04.007_bib0050","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1089\/scd.2011.0159","article-title":"Distinct functional effects for dynamin 3 during megakaryocytopoiesis","volume":"20","author":"Wang","year":"2011","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.exphem.2018.04.007_bib0051","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1074\/jbc.M707307200","article-title":"PINCH-1 regulates the ERK-Bim pathway and contributes to apoptosis resistance in cancer cells","volume":"283","author":"Chen","year":"2008","journal-title":"J Biol Chem"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X18302169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X18302169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:34:06Z","timestamp":1759566846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X18302169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":51,"alternative-id":["S0301472X18302169"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2018.04.007","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental and integrative analyses identify an ETS1 network downstream of BCR-ABL in chronic myeloid leukemia (CML)","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2018.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}